65|10000|Public
50|$|Intrathecal <b>administration</b> <b>of</b> <b>doses</b> {{greater than}} 300 pmol {{produced}} motor impairment in mice.Con-G, Con-R and Con-L cause behavioral toxicity at similar doses. Thus {{the difference in}} the C-terminal sequence might affect the anticonvulsant and behavioral toxicity profile.|$|E
50|$|In calves, a 100% {{morbidity}} rate after being fed {{a dose of}} 40.5 mg/kg bodyweight of Riddelline N-oxide was observed. After <b>administration</b> <b>of</b> <b>doses</b> of 15 - 20 mg/kg/day for 20 days, N-oxide caused seneciosis in cattle. Main clinical signs hereof are malaise, depression, erratic or unpredictable behavior, aimless walking and ataxia. Gross pathological finding are lesions in liver tissues and the central nervous system.|$|E
50|$|In {{research}} on mice, <b>administration</b> <b>of</b> <b>doses</b> greater than 5 μg/kg of epibatidine caused a dose-dependent paralyzing {{effect on the}} organism. With doses over 5 μg/kg, symptoms included hypertension (increased blood pressure), paralysis in the respiratory system, seizures, and, ultimately, death. The symptoms do, however, change drastically when lower doses are given. Mice became resistant to pain and heat {{with none of the}} negative effects of higher doses.|$|E
40|$| <b>administration</b> <b>of</b> lethal <b>doses</b> {{resulted}} in cessation of|$|R
50|$|Oral <b>administration</b> <b>of</b> a <b>dose</b> <b>of</b> a {{calcium salt}} in a gel has been advised by some veterinarians.|$|R
50|$|Wooden chest {{syndrome}} is a rigidity {{of the chest}} following the <b>administration</b> <b>of</b> high <b>doses</b> <b>of</b> opioids during anaesthesia.|$|R
5000|$|Studies {{carried out}} to {{determine}} whether halostachine might be responsible for causing [...] "ryegrass staggers" [...] in Australia involved the <b>administration</b> <b>of</b> <b>doses</b> up to 100 mg/kg, i.v., in sheep, and 100 mg/kg, i.p., in guinea pigs, without any indication of lethality. Although apparently adrenergic effects were evident in the guinea pigs (see [...] "Pharmacology", above), the investigators concluded that halostachine was unlikely to {{be the cause of}} the [...] "staggers" [...] syndrome.|$|E
5000|$|Microdosing (or micro-dosing) is a {{technique}} for studying the behaviour of drugs in humans through the <b>administration</b> <b>of</b> <b>doses</b> so low ("sub-therapeutic") {{they are unlikely to}} produce whole-body effects, but high enough to allow the cellular response to be studied. This is called a [...] "Phase 0 study" [...] and is usually conducted before clinical Phase I to predict whether a drug is viable for the next phase of testing. Human Microdosing aims to reduce the resources spent on non-viable drugs and the amount of testing done on animals.|$|E
40|$|In Caucasian {{volunteers and}} {{patients}} plasma sparfloxacin concentrations reached {{a peak of}} 1. 2 - 1. 5 mg/L between 3 and 6 h after a single 400 mg dose; T ranged from 16 to 22 h. The peak plasma concentration and the area under the plasma concentration-time curve exhibited dose-related increases but a slight decrease in the extent of absorption was observed following <b>administration</b> <b>of</b> <b>doses</b> above those recommended for clinical use. Renal clearance did not exceed 10...|$|E
50|$|For {{more than}} 51 {{years it has}} been known that the <b>administration</b> <b>of</b> low <b>doses</b> <b>of</b> {{antibacterial}} agents promotes the growth of farm animals to increase weight gain.|$|R
40|$|The {{concentration}} of serum thyroglobulin {{was measured in}} sera of subjects with various thyroid disorders, {{before and after the}} <b>administration</b> <b>of</b> tracer <b>doses</b> <b>of</b> 131 I. The mean serum human thyroglobulin (hTg) concentration before <b>administration</b> <b>of</b> the isotope was 35. 2 ng/ml± 7. 8 (SE) in 13 subjects and 36. 3 ng/ml± 7. 9 (SE) 24 h after the <b>administration</b> <b>of</b> 131 I. The data indicate that no significant release of thyroglobulin occurs 24 h after the <b>administration</b> <b>of</b> tracer <b>doses</b> <b>of</b> 131 I. In 2 of the 3 subjects, however, in whom samples were obtained at 4 and 8 h after diagnostic <b>administration</b> <b>of</b> 131 I, a modest rise in serum Tg levels was observed. Determinations of serum thyroglobulin levels within 24 h after the <b>administration</b> <b>of</b> a tracer <b>dose</b> <b>of</b> 131 I are nevertheless valid providing one allows sufficient time to elapse for tracer decay. © 1981, Italian Society of Endocrinology (SIE). All rights reserved. SCOPUS: ar. jinfo:eu-repo/semantics/publishe...|$|R
40|$|The Pseudonaja genus (Brown snakes) {{is widely}} {{distributed}} across Australia and bites account for significant mortality. Venom-induced consumption coagulopathy (VICC) and, less often, early cardiovascular collapse occur following envenoming by these snakes. We have previously examined possible mechanism(s) behind the early cardiovascular collapse following Papuan taipan (Oxyuranus scutellatus) envenoming. In the present study, we investigate early cardiovascular collapse in anaesthetized rats following <b>administration</b> <b>of</b> eastern brown snake (Pseudonaja textilis) venom, {{and prevention of}} this effect with prior <b>administration</b> <b>of</b> ‘priming’ <b>doses</b> (i. e. <b>doses</b> <b>of</b> venom which caused a transient hypotensive response) of venom. P. textilis venom (5 – 10 μg/kg, i. v.) induced cardiovascular collapse in anaesthetized rats, characterized by a rapid decrease in systolic blood pressure until non recordable. Prior <b>administration</b> <b>of</b> ‘priming’ <b>doses</b> <b>of</b> P. textilis venom (2 and 3 μg/kg) or, at least, 4 – 5 <b>doses</b> <b>of</b> O. scutellatus (2 μg/kg, i. v.) or Daboia russelii limitis (20 μg/kg, i. v.) venoms prevented cardiovascular collapse induced by P. textilis venom. Moreover, early collapse was also inhibited by prior <b>administration</b> <b>of</b> 2 discrete <b>doses</b> <b>of</b> Acanthophis rugosus venom. Prior <b>administration</b> <b>of</b> commercial polyvalent snake antivenom (500 – 3000 units/kg, i. v.) or heparin (300 units/kg, i. v.) also inhibited P. textilis venom-induced cardiovascular collapse. Our results indicate that P. textilis venom-induced cardiovascular collapse can be prevented by prior <b>administration</b> <b>of</b> sub-lethal <b>doses</b> <b>of</b> venom from P. textilis, O. scutellatus, A. rugosus and D. russelii limitis. This suggests that sudden cardiovascular collapse following envenoming is likely to involve a common mechanism/pathway activated by different snake venoms...|$|R
40|$|The {{pharmacokinetics}} {{of increasing}} doses of an intrarectal Cinchona alkaloid combination containing 96. 1 % quinine, 2. 5 % quinidine, 0. 68 % cinchonine, and 0. 67 % cinchonidine (Quinimax) {{was compared to}} that of parenteral regimens in 60 children with moderate malaria. Quinine exhibited a nonlinear pharmacokinetics, suggesting a saturation of rectal resorption. When early rejections appeared, blood quinine concentrations decreased by 30 to 50 % and were restored by an immediate half-dose administration of the drug. Rectal <b>administration</b> <b>of</b> <b>doses</b> of 16 or 20 mg/kg of body weight led to concentration-time profiles in blood similar to those of parenteral regimens and could be an early treatment of childhood malaria...|$|E
40|$|LY 83583, a quinolinedione, and LY 1 51 364, a quinoxalinedione, were {{developed}} as inhibitors of leukotriene (slow reacting sub-stance of anaphylaxis) release. They preferentially inhibited {{the release of}} leukotrienes over histamine from fragmented guinea-pig lung and rat peritoneal cells in vitro, {{regardless of whether the}} mediators were released immunologically by antigen or chemically by the divalent cationic ionophore, A 231 87. Similar results were obtained with rat pentoneal cells in vivo. In that system, comparison of LY 83583 with disodium cromoglycate showed theformer to preferentially inhibit release of leukotrienes, whereas the latter favored inhibition of histamine release. LY 83583 did not significantly decrease antigen-induced broncho-spasm in guinea pigs after i. v. <b>administration</b> <b>of</b> <b>doses</b> that approached toxic levels. In addition, LY 83583 did not antagoniz...|$|E
40|$|Given {{the long-standing}} {{tradition}} of strict enforcement of radiopharmaceuticaladministration regulations {{and the current}} climate of concern regarding protection against mal practice litigation, the nuclear medicine physician is {{acutely aware of the}} need to develop procedures for assuring quality control {{every step of the way}} from radiopharmaceutical preparation to dose administration. Just as important as the delivery of the dose is the system of records that serves as evidence that dose delivery was in fact correct. We will describe a record-keeping system for radiopharmaceutical accountability that simplifies the paperwork and minimizes human error in the preparation and <b>administration</b> <b>of</b> <b>doses</b> to patients. The system has been used in our clinic for several years and has been commended by representatives of several regulatory agencies. Even the smallest nuclea...|$|E
50|$|Consider the <b>administration</b> <b>of</b> {{a single}} <b>dose</b> <b>of</b> {{activated}} charcoal to bind any oleandrin {{left in the}} gastrointestinal tract.|$|R
2500|$|No {{immediate}} {{short term}} effects on mood or behavior were found from the <b>administration</b> <b>of</b> [...] <b>doses</b> <b>of</b> testosterone for 10 weeks on 43 healthy men. [...] A correlation between testosterone and risk tolerance in career choice exists among women.|$|R
50|$|Desensitization {{involves}} daily <b>administration</b> <b>of</b> progressive <b>doses</b> <b>of</b> salicylate. This {{process is}} usually performed as an inpatient, with a crash-cart {{at the bedside}} over a six-day period, beginning with 25 mg of I.V. lysine-aspirin and progressing to 500 mg if tolerated.|$|R
40|$|Objective of {{the present}} work was to {{evaluate}} alkaloids extract of Fumaria capreolata for possible toxicity and antioxidant potential. Antioxidant activity was measured using the 2, 2 0 -azino-bis (3 -ethylbenzothiazoline- 6 -sulfonic acid) (ABTS) and the 2, 2 -diphenyl- 1 -picrylhydrazyl (DPPH) scavenging. The significant correlations exist between extract concentrations and percentage scavenging activity of radicals in all models. These results clearly indicate that the alkaloid extract from Fumaria capreolata is effective free radical scavenger and chain breaking antioxidant. In order to assess the toxicity of the alkaloids extract, acute and cell toxicological {{studies were carried out}} in mice and erythrocytes. After acute <b>administration</b> <b>of</b> <b>doses</b> 200, 1000 and 2000 mg/kg of total alkaloids, there were no remarkable changes in general appearance and no deaths occurred in any experimental group in both sexes...|$|E
40|$|The {{acute and}} subchronic {{toxicity}} tests {{were carried out}} on the aquaous extract of the leaves of Stevia rebaudiana Bertonii M. obtained from the Balai Penelitian Tanaman Obat in Tawamangu, Surakarta, Central Java. The acute toxicity test {{was done by the}} Weil's method (1952) on mice and the subchronic toxicity test was done on rats by a method developed by the Pharmaceutical Research and Deve­lopment Center of the National Institute of Health Research and Development, Jakarta. The results are : the leaves of Stevia rebaudiana Bertonii M. can be grouped into substances which are "practically non-toxic" based on the criteria used by Gleason (1969) and the oral <b>administration</b> <b>of</b> <b>doses</b> up to 320 mg/ 100 g body weight daily for 6 months showed no negative effect on the organs of the animals examined. </p...|$|E
40|$|Multiple model (MM) {{design and}} {{stochastic}} control of dosage regimens permits essentially {{full use of}} all {{the information contained in}} either a nonparametric EM (NPEM) population pharmacokinetic model or in an MM Bayesian updated parameter set, to achieve and maintain selected therapeutic goals with optimal precision (least predicted weighted squared error). The regimens are visibly more precise than those developed using mean parameter values. Bayesian feedback has now also been incorporated into the MM software. An evaluation of MM dosage design using an NPEM population model versus dosage design based on conventional mean population parameter values is presented, using a population model of Vancomycin. Further feedback control was evaluated, also incorporating realistic simulated uncertainties in the clinical environment such as those in the preparation and <b>administration</b> <b>of</b> <b>doses.</b> INTRODUCTION Previous work from this laboratory has shown the utility of NPEM population pharmacokine [...] ...|$|E
5000|$|No {{immediate}} {{short term}} effects on mood or behavior were found from the <b>administration</b> <b>of</b> supraphysiologic <b>doses</b> <b>of</b> testosterone for 10 weeks on 43 healthy men. [...] A correlation between testosterone and risk tolerance in career choice exists among women.|$|R
50|$|A {{temporary}} desensitization method {{involves the}} <b>administration</b> <b>of</b> small <b>doses</b> <b>of</b> an allergen to produces an IgE-mediated response {{in a setting}} where an individual can be resuscitated {{in the event of}} anaphylaxis; this approach, through uncharacterized mechanisms eventually overrides the hypersensitive IgE response.|$|R
50|$|Treatment <b>of</b> HSH {{involves}} <b>administration</b> <b>of</b> high <b>doses</b> <b>of</b> magnesium salts. These salts may {{be taken}} orally or otherwise (e.g. subcutaneously). This treatment works by increasing magnesium absorption through the non-TRPM6 mediated paracellular uptake pathways. This treatment must be continued throughout life.|$|R
40|$|Accumulating {{lines of}} {{experimental}} and clinical evidence {{suggest that the}} prototypic, orthosteric GABAB receptor agonist, baclofen, may possess therapeutic potential for treatment of alcohol use disorder (AUD). At preclinical level, acute or repeated treatment with non-sedative doses of baclofen has repeatedly been reported to suppress several alcohol-motivated behaviors, including alcohol drinking, in rats and mice. At clinical level, <b>administration</b> <b>of</b> <b>doses</b> of baclofen ranging from low to extremely high doses {{has been found to}} suppress alcohol consumption, craving for alcohol, and alcohol withdrawal signs and symptoms in patients affected by AUD, confirming that baclofen may represent a promising option for treatment of AUD. A more recent avenue of research is represented by generalization of baclofen effects to the positive allosteric modulators of the GABAB receptor: preclinical data collected to date suggest that these compounds reproduce, with a much higher therapeutic index, several suppressing effects of baclofen on alcohol-motivated behaviors...|$|E
40|$|Eleven {{patients}} each received gentamicin sulfate, tobramycin, and sisomicin by continuous intravenous infusion {{after an}} initial loading dose. Subsequent doses of antibiotic were adjusted {{in an attempt to}} maintain constant serum concentrations. There was considerable variation in the serum concentration from patient to patient and in the same patient from day to day with each drug. Although the dosages of gentamicin sulfate and tobramycin were similar, the serum concentrations of the latter drug were consistently lower. Despite the daily <b>administration</b> <b>of</b> <b>doses</b> of at least 300 mg of gentamicin and tobramycin per m 2 and 160 mg of sisomicin per m 2, nephrotoxicity occurred in only three patients. This is a low frequency of nephrotoxicity, considering the dosages of drug administered. Although therapeutic efficacy was not an objective of this study, 8 of 11 documented infections were cured. This approach to the administration of aminoglycoside antibiotics deserves therapeutic trials...|$|E
40|$|Herbal {{pharmaceuticals}} and nutraceuticals {{are growing}} in popularity worldwide. These herbal remedies, however natural, can cause some serious damaging {{effects on the}} vital organs of the body due to inadequacy in standardization and safety regulations. A 24 hour acute toxicity study was carried out to ascertain the risk of acute intoxication of selected doses (200 to 8, 000 mg/kg body weight) of the Acalypha torta leaves ethanolic extract in mice. Subacute toxicity was also assessed following intraperitoneal <b>administration</b> <b>of</b> <b>doses</b> 2000 mg/kg body weight caused loss of appetite, increased respiratory rate, convulsion and reduced responses to pains. Observed pathological changes after 28 day subacute toxicity study in rats were necrosis, follicular disorganization, inflammatory reactions, fibrosis and bronchial dilatation. These changes were seen in the liver, spleen, brain, heart, kidney and lung sections. These findings may suggest that prolonged use of the extract could lead to organ damage...|$|E
40|$|Following the {{intravenous}} <b>administration</b> <b>of</b> a tracer <b>dose</b> (1. 7 microgram) of [3 H]-mebendazole to a man, an elimination half-life of 1. 16 h {{was observed}} and {{the volume of}} distribution was calculated to be 2. 03 l/kg. After oral <b>administration</b> <b>of</b> the same <b>dose,</b> an elimination half-life of 0. 74 h was observed. The bioavailability of mebendazole from the solution {{was found to be}} 17 %...|$|R
3000|$|... 1 : Figure S 8), as expected, {{showed that}} the <b>administration</b> <b>of</b> two <b>doses</b> (2 [*]×[*] 20 [*]MBq[*]=[*] 40 [*]MBq) was more {{effective}} in tumour growth inhibition than application <b>of</b> a single <b>dose</b> (20 [*]MBq). As shown with in vitro autoradiography (Additional file [...]...|$|R
40|$|Five {{patients}} who developed neutropenia following intravenous <b>administration</b> <b>of</b> high <b>dose</b> oxacillin for serious Staphylococcus aureus infection are described. Neutropenia was reversible with cessation of intravenous oxacillin therapy. Two patients were continued on oral oxacillin without untoward effects...|$|R
40|$|The {{production}} of kallidin from guinea-pig and ox serum kallidinogen by {{the action of}} guinea-pig serum-kallikrein or human salivary kallikrein was inhibited by various analgesic-antipyretic drugs. This effect was obtained in vitro with concentrations of inhibitors which do not inhibit the smooth-muscle-stimulating action of the various polypeptides, but similar to the concentrations needed in vivo to obtain an anti-inflammatory action. The vasodepressor action of intravenously administered human salivary kallikrein in the anaesthetized dog was very markedly inhibited by the intravenous <b>administration</b> <b>of</b> <b>doses</b> of various analgesic-antipyretic drugs which only partially antagonized the responses to kallidin and bradykinin and which left the vasodepressor responses to histamine, acetylcholine and 5 -hydroxytryptamine unaffected. In rabbits the accumulation of protein-bound dye at the site of intradermal injection of human salivary kallikrein and guinea-pig serum-kallikrein, but not of bradykinin and kallidin, was inhibited very markedly by the systemic administration of various analgesic-antipyretic drugs...|$|E
40|$|International audienceThe {{efficacy}} of anti-angiogenic therapies on cancer patients {{is limited by}} the emergence of drug resistance, urging the search for second-generation drugs. In this study, we screened an academic chemical library (DCM, University of Grenoble-Alpes) and identified a leader molecule, COB 223, that inhibits endothelial cell migration and proliferation. It inhibits also Lewis lung carcinoma (LLC/ 2) cell proliferation whereas it does not affect fibroblast proliferation. The anti-angiogenic activity of COB 223 was confirmed using several in vitro and in vivo assays. In a mouse LLC/ 2 tumor model, ip <b>administration</b> <b>of</b> <b>doses</b> as low as 4 mg/kg COB 223 efficiently reduced the tumor growth rate. We observed that COB 223 inhibits endothelial cell ERK 1 / 2 phosphorylation induced by VEGF, FGF- 2 or serum and that it acts downstream of PKC and upstream of Ras. This molecule represents a novel anti-angiogenic and anti-tumorigenic agent with an original mechanism of action that deserves further development as an anti-cancer drug...|$|E
40|$|Nontoxic {{naturally}} occurring metabolite of estrogen namely 2 -methoxyestradial (2 ME 2) found in serum and urine {{has been shown}} to be antitumorigenic in various tumor models including the prostate. A recent study conducted in breast cancer cells showed growth stimulatory effect of 2 ME 2 when used at low concentrations (10 - 750 nM). Studies from our laboratory has demonstrated prostate tumor preventive ability of 50 mg/kg 2 -ME 2. In this study we show that concentrations of 2 -ME 2 as low as 1 μM is sufficient to inhibit proliferation and induce apoptosis in androgen responsive LNCaP cells. In addition oral <b>administration</b> <b>of</b> <b>doses</b> lower than 50 mg/kg prevented prostate tumor development in LNCaP xenograft model. The observed tumor growth inhibition was associated with induction of apoptosis, increased expression of Wee 1 kinase and p 34 cdc 2. In addition administration of 25 mg/kg 2 -ME 2 prevented tumor development significantly that is associated with reduction in serum PSA levels...|$|E
5000|$|The {{solution}} of this differential equation {{is useful in}} calculating the concentration after the <b>administration</b> <b>of</b> a single <b>dose</b> <b>of</b> drug via IV bolus injection: ...|$|R
40|$|Received on 23 - 03 - 2014 Accepted on 10 - 04 - 2014 Back ground: Antimicrobial prophylaxes for the {{surgical}} patients remain {{one of the}} major types of medication errors in the hospitals. So, any error in the <b>administration</b> <b>of</b> <b>dose</b> <b>of</b> antimicrobial prophylaxis increases the rates of surgical site infections. The Aim of the study was not only to evaluate the risk of surgical wound infection and hospital acquired infections among patients with and without tolerable antibiotic prophylaxis but also, to offer simulations to forecast the numerous internal factors of hospital infection and surgical wound infection. Optimal and ideal usage of antimicrobial prophylaxis involve proper case selection; use of suitable agents; route <b>of</b> <b>administration,</b> appropriate <b>dosing,,</b> timing, and duration; and intraoperative <b>dosing.</b> The use <b>of</b> different antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure, was compared and evaluated in different patients with standard guidelines. Method/Design of study: A prospective cohort study was performed over 12 months, with data collected by pharmacists through visits to different Surgical (II & III), Medical (I, II & III) and ENT ward of BVH (Bahawa...|$|R
40|$|We {{describe}} {{a case of}} pericardial tamponade as an initial manifestation of systemic lupus erythematosus (SLE). Although pericarditis or pericardial effusion is the common cardiac complication of SLE, tamponade is unusual. Treatment consists <b>of</b> pericardiocentesis, <b>administration</b> <b>of</b> high <b>dose</b> glucocorticoid an antimalarial drug...|$|R
